Test LB : Analyst and Investor Call to Be Held on August 5, 2016
LUXEMBOURG (August 2, 2016) – ConvaTec today announced that it will hold an analyst and investor call to discuss 2016 second quarter results on Friday, August 5, 2016. Paul Moraviec, CEO and Nigel Clerkin, CFO will host the call at 9:00 AM ET live via telephone.
To participate in the conference call:
Conference ID#: 56355966
Participants should dial in 10 minutes prior to the start of the call. The Company’s 2016 Second Quarter Report will be available on the Company’s website prior to the call under the Investors tab at www.convateccorporate.com.
For more information, please contact firstname.lastname@example.org.
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.